Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Lingxi Li

机构:Shenyang Pharmaceutical University · ORCID:0000-0002-9471-9774

发表论文 49 篇 · 总被引 962 次 · h-index 18

代表论文

  • Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses (2025 · Cell Metabolism · 被引 66)
  • Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics (2024 · Gut Microbes · 被引 19)
  • Trim45: An emerging E3 ubiquitin ligases in cancer (2025 · Cellular Signalling · 被引 18)
  • Impact of Different Oak Chips’ Aging on the Volatile Compounds and Sensory Characteristics of Vitis amurensis Wines (2022 · Foods · 被引 18)
  • Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype (2025 · Cell Reports · 被引 17)
  • Polyphenols in different parts of Moringa oleifera Lam.: Composition, antioxidant and neuroprotective potential (2025 · Food Chemistry · 被引 15)